Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $232,153 - $258,329
-1,439 Reduced 31.52%
3,127 $511,000
Q2 2022

Aug 15, 2022

SELL
$168.19 - $186.01 $29,769 - $32,923
-177 Reduced 3.73%
4,566 $811,000
Q1 2022

May 16, 2022

BUY
$158.14 - $179.59 $403,731 - $458,493
2,553 Added 116.58%
4,743 $841,000
Q4 2021

Feb 14, 2022

SELL
$155.93 - $173.01 $12,474 - $13,840
-80 Reduced 3.52%
2,190 $375,000
Q3 2021

Nov 15, 2021

BUY
$161.5 - $179.47 $20,349 - $22,613
126 Added 5.88%
2,270 $367,000
Q2 2021

Aug 16, 2021

SELL
$159.48 - $171.07 $104,459 - $112,050
-655 Reduced 23.4%
2,144 $353,000
Q1 2021

May 14, 2021

BUY
$153.07 - $170.48 $428,442 - $477,173
2,799 New
2,799 $460,000
Q1 2020

May 15, 2020

SELL
$111.14 - $153.99 $283,295 - $392,520
-2,549 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$127.5 - $146.44 $37,357 - $42,906
293 Added 12.99%
2,549 $372,000
Q3 2019

Nov 14, 2019

BUY
$126.95 - $142.14 $11,552 - $12,934
91 Added 4.2%
2,256 $292,000
Q2 2019

Aug 14, 2019

BUY
$131.15 - $144.24 $20,328 - $22,357
155 Added 7.71%
2,165 $302,000
Q1 2019

May 15, 2019

SELL
$125.72 - $139.79 $35,327 - $39,280
-281 Reduced 12.27%
2,010 $281,000
Q4 2018

Feb 14, 2019

BUY
$122.84 - $147.84 $36,237 - $43,612
295 Added 14.78%
2,291 $296,000
Q3 2018

Nov 14, 2018

BUY
$121.58 - $142.88 $37,081 - $43,578
305 Added 18.04%
1,996 $276,000
Q2 2018

Aug 14, 2018

SELL
$119.4 - $131.76 $10,149 - $11,199
-85 Reduced 4.79%
1,691 $205,000
Q1 2018

May 15, 2018

BUY
$125.1 - $148.14 $37,905 - $44,886
303 Added 20.57%
1,776 $228,000
Q4 2017

Feb 14, 2018

SELL
$131.22 - $143.62 $131,088 - $143,476
-999 Reduced 40.41%
1,473 $206,000
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $320,049 - $334,659
2,472
2,472 $321,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Dsc Advisors, L.P. Portfolio

Follow Dsc Advisors, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dsc Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Dsc Advisors, L.P. with notifications on news.